Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
607,324
-
Shares change
-
-36,515
-
Total reported value, excl. options
-
$67,362,554
-
Value change
-
-$4,554,735
-
Put/Call ratio
-
89%
-
Number of buys
-
25
-
Number of sells
-
-34
-
Price
-
$110.71
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2018
97 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q4 2018.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 607,324 shares
.
Largest 10 shareholders include UBS Group AG (63,537 shares), MORGAN STANLEY (59,972 shares), ROYAL BANK OF CANADA (47,489 shares), MURPHY CAPITAL MANAGEMENT INC (40,989 shares), Virtu Financial LLC (33,489 shares), Strategic Financial Services, Inc, (26,463 shares), CITADEL ADVISORS LLC (21,517 shares), BANK OF AMERICA CORP /DE/ (18,919 shares), MOGY JOEL R INVESTMENT COUNSEL INC (18,705 shares), and RAYMOND JAMES & ASSOCIATES (16,720 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.